维生素D对终末期肾病患者心血管保护研究进展(5)
[18] Agarwal R，Georgianos PI. Con： Nutritional vitamin D replacement in chronic kidney disease and end?stage renal disease. Nephrol Dial Transplant，2016，31(5)：706?713.
[19] Zoccali C，Mallamaci F. Moderator’s view： Vitamin D deficiency treatment in advanced chronic kidney disease： a close look at the emperor's clothes. Nephrol Dial Transplant，2016，31(5)：714?716.
[20] Lessard M，Ouimet D，Leblanc M，Nadeau?Fredette AC，Bell R，Lafrance JP，Pichette V，Vallée M.Comparison of oral and intravenous alfacalcidol in chronic hemodialysis patients.BMC Nephrol，2014，15：27.
[21] Dudenkov DV，Yawn BP，Oberhelman SS，Fischer PR，Singh RJ，Cha SS，Maxson JA，Quigg SM，Thacher TD. Changing incidence of serum 25?hydroxyvitamin D values above 50 ng/mL： a 10?year population?based study. Mayo Clin Proc，2015，90(5)：577?586.
[22] Christakos S，Dhawan P，Verstuyf A，Verlinden L，Carmeliet G.Vitamin D： Metabolism，Molecular Mechanism of Action，and Pleiotropic Effects. Physiol Rev，2016，96(1)：365?408.
[23] Giakoumis M，Tsioufis C，Dimitriadis K，Sonikian M，Kasiakogias A，Andrikou E，Kalos T，Konstantinidis D，Filis K，Petras D，Tousoulis D.Effects of oral paricalcitol therapy on arterial stiffness and osteopontin in hypertensive patients with chronic kidney disease and secondary hyperparathyroidism. Hellenic J Cardiol，2018， pii： S1109?9666(17)30504?3.
(收稿日期：2018?07?19)
(本文编辑：杨江瑜), http://www.100md.com(冯世栋 田秀娟 王妍 王汉民)
[19] Zoccali C，Mallamaci F. Moderator’s view： Vitamin D deficiency treatment in advanced chronic kidney disease： a close look at the emperor's clothes. Nephrol Dial Transplant，2016，31(5)：714?716.
[20] Lessard M，Ouimet D，Leblanc M，Nadeau?Fredette AC，Bell R，Lafrance JP，Pichette V，Vallée M.Comparison of oral and intravenous alfacalcidol in chronic hemodialysis patients.BMC Nephrol，2014，15：27.
[21] Dudenkov DV，Yawn BP，Oberhelman SS，Fischer PR，Singh RJ，Cha SS，Maxson JA，Quigg SM，Thacher TD. Changing incidence of serum 25?hydroxyvitamin D values above 50 ng/mL： a 10?year population?based study. Mayo Clin Proc，2015，90(5)：577?586.
[22] Christakos S，Dhawan P，Verstuyf A，Verlinden L，Carmeliet G.Vitamin D： Metabolism，Molecular Mechanism of Action，and Pleiotropic Effects. Physiol Rev，2016，96(1)：365?408.
[23] Giakoumis M，Tsioufis C，Dimitriadis K，Sonikian M，Kasiakogias A，Andrikou E，Kalos T，Konstantinidis D，Filis K，Petras D，Tousoulis D.Effects of oral paricalcitol therapy on arterial stiffness and osteopontin in hypertensive patients with chronic kidney disease and secondary hyperparathyroidism. Hellenic J Cardiol，2018， pii： S1109?9666(17)30504?3.
(收稿日期：2018?07?19)
(本文编辑：杨江瑜), http://www.100md.com(冯世栋 田秀娟 王妍 王汉民)